Use our Project or Categories filter to narrow down your news search.

Reset

Should you get a home genetic test?

Harvard health Publishing |
February 2019
Press

More and more people want to explore their own medical data, and a DTC genetic test is one way to begin to understand some aspects of your future health.

The genetic counselor with a $4,000 DNA test

Bloomberg |
July 2019
Press, Video

At a new clinic in Boston, genetic counselor Carrie Blout helps healthy patients get their DNA tested for predispositions to more than 2500 diseases. Bloomberg’s Aki Ito goes through the testing herself, trialing a controversial technology at the forefront of modern medicine.

Should you find out if you’re at risk of Alzheimer’s?

The Wall Street Journal |
July 2019
Press

Dr. Robert Green on learning of your genetic risk to developing Alzheimer’s quotes:  “Not everything has a pill or medical-prevention plan, but many information-seeking persons can find all sorts of benefits in better understanding their risk of future disease.”

The promises and pitfalls of gene sequencing for newborns

NPR |
July 2019
Press

A decade ago, it seemed inevitable that every newborn would get a complete gene scan. But there are technical challenges and practical concerns.Dr. Robert Green, from Brigham and Women’s Hospital in Boston, voiced one view about doing that: “If sequencing reveals health risks at any point in life, and if that’s good, then it’s better … Continued

Blood samples reveal valuable data — and life-changing surprises for donors

The Boston Globe |
July 2019
Press

Kristine Trudeau agreed to donate a sample of blood to the Partners HealthCare Biobank, a resource for researchers across the Partners hospital network — including the Brigham and Massachusetts General. By analyzing large numbers of blood samples, scientists can learn how genes contribute to disease. Trudeau shares her experiences as being one the many participants … Continued

G2P Newsletter June 2019

June 2019
G2P News

G2P’s summer began with our team members participating in the Boston Athletic Association 10K on Sunday June 23rd! Over the past few months, G2P faculty have attended numerous conferences nationwide, been featured in podcasts discussing the new preventive genomics clinic, and engaged with leaders in science, business, and industry in support of the Franca Fund.

Sanford Health taps Harvard, Brigham and Women’s for genetic screening study

Genome Web |
June 2019
Press

Under the four-year collaboration, experts in genomic medicine from Harvard and Brigham and Women’s will help guide Sanford researchers in using and interpreting data collected through the Sanford Chip, a $49 pharmacogenomic test to identify genetic risk factors for medication use and more accurately prescribe medications.

Carrie Blout on discovering whats in your genome

SoundCloud |
May 2019
Podcast

What would happen if everyone got their genome sequenced? This question is no longer the stuff of science fiction. Instead, it is a research question that Senior Genetic Counselor Carrie Blout and her colleagues at the Genomes2People initiative at Brigham and Women’s hospital are trying to answer. We discuss the medical, psychological, and economic impact … Continued

Don’t count on 23andMe to detect most breast cancer risks, study warns

New York Times |
April 2019
Press

Nearly 90 percent of participants who carried a BRCA mutation would have been missed by 23andMe’s test, geneticists found. Dr Robert Green comments, “I think people have the right to their own genetic information, but with that right comes a responsibility. If you are going to go around the medical mainstream, read the caveats.”

DNA testing could save young lives through early intervention

The Harvard Gazette |
March 2019
Press

Pediatric oncologist Dr. Lisa Diller, the Lillian Gollay Knafel Fellow at the Radcliffe Institute for Advanced Study, is exploring genetic testing in newborns that could help them escape severe health consequences.

G2P Newsletter March 2019

March 2019
G2P News

Spring saw accomplishments by team members through numerous projects. G2P officially kicked-off the PeopleSeq consortium in Boston this January! Our very own, Carrie Blout, MS, CGC, was one of 86 Partner’s individuals awarded the Partners In Excellence Award.

Is it too soon to consider genome sequencing for newborns?

Medium |
March 2019
G2P Blog

Parents and clinicians have their own ideas about newborn genome sequencing. Dr. Robert Green, principal investigator of the BabySeq Project, shares a detailed analysis of the results from the study and his thoughts on the utility of genomic sequencing for newborns in clinical care.

G2P News: Carrie Blout receives 2019 Partners In Excellence award

G2P News |
March 2019
G2P News

Carrie Blout, MS, CGC, Director of Research Development and Senior genetic Counselor at Genomes2People was selected as a 2019 Individual recipient of the Partners In Excellence Awards- awarded to individuals at Partners HealthCare for going above and beyond in their work efforts.

G2P News: PeopleSeq launch

G2P News |
January 2019
G2P News

The PeopleSeq Consortium officially kicked off their NIH- funded project in Boston, bringing together a cohort of leading academic and industry collaborators.

Genetically sequencing healthy babies yielded surprising results

Leapsmag |
January 2019
Press

As principal investigator on the BabySeq Project, Dr. Robert Green shares the findings from the project along with discussion on the expectations and benefits of sequencing healthy babies. Green states, “Suddenly the information available in the genome of even an apparently healthy individual is looking more robust, and the prospect of preventive genomics is looking … Continued

Baby sequencing steps

Nature Reviews Genetics |
January 2019
Press

In the BabySeq Study, a total of 88% of sequenced neonates had carrier status for one or more rare genetic variants known to be associated with recessive diseases.

Newborn genomic sequencing detects unanticipated disease risk factors

Brigham Women's Hospital |
January 2019
Press Release

Press Brief: The BabySeq project reports that out of the 159 newborns that were randomized to receive genomic sequencing, 15 were found to have a genetic variant for which there was a strong evidence of increased risk of a disorder that presents or is clinically manageable during childhood.

More than 10% of healthy people have monogenic risk variants

RareDR |
December 2018
Press

Robert Green, MD, MPH, the projects’ principal investigator suggests “These results are unexpected and exciting, suggesting that if we examine enough well-established, disease-associated genes, we will unearth monogenic risk variants in more than 10 percent of purportedly healthy individuals.”

Dr. Robert Green on the impact of individual genomic data

Harry Glorikian |
December 2018
Podcast

Harry Glorikian guest this week, Dr. Robert Green, is a professor of medicine and genetics at Harvard Medical School and director of the Genomes To People research program at Brigham & Women’s Hospital and the Broad Institute of Harvard and MIT. They dig into the individual genome, how genomic data is being used, and the impact … Continued

G2P Newsletter December 2018

December 2018
G2P News

This Fall, G2P has had exciting updates with a new PeopleSeq grant. Our team has traveled from San Diego, Atlanta, and Fort Detrick to Basel, Zurich, and Barcelona, to several conferences, presenting new data from our translational genomics research projects.

Who do you think you are?

O Magazine |
December 2018
Press

At-home genetic testing can  help you understand your biology. But before delving into your DNA, consider the caveats.

G2P team presents data nationally and abroad

November 2018
G2P News

From San Diego, Atlanta and Fort Detrick to Basel, Zurich and Barcelona, our team traveled to several conferences this fall, presenting new data from our translational genomics research projects.

Studying personal genomics: Expanding the pool

Medium |
November 2018
G2P Blog

While a good deal of research has focused on finding information within the human genome that can diagnose rare conditions, far less work has been done to understand the longer-term consequences of identifying genetic risks in apparently healthy people. Read more the PeopleSeq Consoritum from the principal investigator, Dr. Robert Green!